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Mechanical, ischemic, and inﬂammatory injuries to voltage-gated sodium channel (Nav)-rich
membranes of axon initial segments and nodes of Ranvier render Nav channels danger-
ously leaky. By what means?The behavior of recombinant Nav1.6 (Wang et al., 2009) leads
us to postulate that, in neuropathologic conditions, structural degradation of axolemmal
bilayer fosters chronically left-shifted Nav channel operation, resulting in ENa rundown.This
“sick excitable cell Nav-leak” would encompass left-shifted fast- and slow-mode based
persistent INa (i.e., Iwindow and slow-inactivating INa). Bilayer-damage-induced electrophys-
iological dysfunctions of native-Nav channels, and effects on inhibitors on those channels,
should, we suggest, be studied inmyelinated axons, exploiting INa(V,t ) hysteresis data from
sawtooth ramp clamp.We hypothesize that (like dihydropyridines for Ca channels), protec-
tive lipophilic Nav antagonists would partition more avidly into disorderly bilayers than into
the well-packed bilayers characteristic of undamaged, healthy plasma membrane.Whereas
inhibitors using aqueous routes would access all Navs equally, differential partitioning into
“sick bilayer” would co-localize lipophilic antagonists with “sick-Nav channels,” allowing for
more speciﬁc targeting of impaired cells. Molecular ﬁne-tuning of Nav antagonists to favor
more avid partitioning into damaged than into intact bilayers could reduce side effects. In
potentially salvageable neurons of traumatic and/or ischemic penumbras, in inﬂammatory
neuropathies, in muscular dystrophy, in myocytes of cardiac infarct borders, Nav-leak dri-
ven excitotoxicity overwhelms cellular repair mechanisms. Precision-tuning of a lipophilic
Nav antagonist for greatest efﬁcacy in mildly damaged membranes could render it suitable
for the prolonged continuous administration needed to allow for the remodeling of the
excitable membranes, and thus functional recovery.
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Nav CHANNEL GATING MODE TERMINOLOGY
As originally described by Hodgkin and Huxley (1952) voltage-
gated sodium channels (Nav) have a predominant fast mode
of gating. However, for any population of Nav channels, at
any given time, a small fraction will be switching reversibly
between fast-mode and slow mode (Figure 1). Terminology for
Nav kinetics has evolved along with the structure/function stud-
ies propelling the voltage-gated channel ﬁeld and it is some-
times unclear what is meant by “persistent sodium current.”
Thus, before embarking on a discussion of how membrane
injury alters Nav channel behavior and what this might sig-
nify for drug therapies, we show (Figure 1) how we use kinetic
terms. The simpliﬁed schematic is co-labeled with conventional
(current-based) and newer (structure/function-based) terms: Nav
channel conformations can be either Active mode (= fast) or
Relaxed mode (= slow; Villalba-Galea et al., 2008). For transi-
tions between modes, we prefer “mode-switch” to “mode-shift”
(see Lin et al., 2007), since “switch” better evokes a protein
conformation change than does “shift,” which in any case is
easily confounded with the graphical relocation of Boltzmann
curves along a voltage axis, a routine occurrence for both Active
mode and Relaxed mode channels (this will be seen, e.g., in
Figure 3C and Figures 4C,D). The mode-switch conformation
changes, though not well understood in Nav channels (Webb
et al., 2009), are not dependent on voltage (Villalba-Galea et al.,
2008).
THE PROBLEM: Nav CHANNELS GET LEAKY IN SICK
EXCITABLE CELLS
As summarized in Table 1, Nav channels are dangerously leaky
in a multitude of “sick-cell excitable cell” conditions. Mechani-
cal trauma and/or ischemia and/or inﬂammation, and/or various
genetic diseases result in damaged excitable cell membranes. More
speciﬁcally, at Nav-rich membranes, bilayer structure degradation
renders the Nav channels leaky. A CNS trauma example is depicted
in Figure 2A: stretch trauma has caused axolemmal blebbing at the
node of Ranvier. The fully blebbed bilayer, though detached from
the specialized nodal spectrin skeleton (Figure 2C), would still
be well-endowed with Nav1.6 channels. Even in such egregiously
bleb-damaged plasma membrane, Nav channels are capable of
voltage-dependent gating (Milton andCaldwell, 1990). In fact they
gate “too well” (Figure 2B) in that they activate at inappropriately
hyperpolarized (left-shifted) voltages (Shcherbatko et al., 1999;
Tabarean et al., 1999; Wang et al., 2009; Beyder et al., 2010). A Nav
channel whose operation becomes left-shifted in this manner is,
in effect, leaky.
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FIGURE 1 |Two major gating modes. A Nav channel has four voltage
sensor domains and complex gating kinetics; this simpliﬁed scheme
emphasizes voltage-dependent (V ) activation [closed, open (C,O)], plus
inactivation (I) to an open-like but occluded state in each of the two major
modes (Active and Relaxed). The smaller letters (CA. . . and CR. . .) serve as
a reminder that a full kinetic scheme (e.g., Taddese and Bean, 2002; Lenkey
et al., 2011) would have many more states. Structural changes underlying
mode switching, a feature of all voltage-gated proteins, are not yet
understood (Villalba-Galea et al., 2008). During prolonged depolarizations
and hyperpolarizations, inter-mode transitions (vertical arrows), which are
voltage-independent (Villalba-Galea et al., 2008), would drive the Nav
system toward IR and CA (“inactivated” and “resting” in the parlance of
Lenkey et al., 2011), respectively. Macroscopic INa(t ) includes INa-fast (fast,
transient, or broadly speaking, Hodgkin–Huxley type) plus INa-slow (also
variously called “persistent,” “slowly inactivating,” “non-inactivating”),
which ﬂow through open Active and Relaxed mode Nav channels (OA, OR),
respectively. Depolarization-induced repacking of voltage sensor domains
(largely within the trans-bilayer electric ﬁeld) yields net outward gating
charge movement and facilitates C→O transitions. Activation curves, i.e.,
gNa(V ) associated with CA–OA or with CR–OR, yield the “Boltzmann”
sigmoid curves that summarize voltage-dependent fast or slow-gating
energetics. Hyperpolarizing and depolarizing Boltzmann shifts are called
“left shifts” or “right-shifts” respectively. The process by which the Nav
“inactivation particle” binds (OA → IA), though not inherently voltage
dependent, is rate-limited by (hence coupled to) the voltage-dependent
process of fast activation (Wang et al., 2009; Boucher et al., 2012). Thus,
when activation [gNa-fast(V )] left shifts due to bilayer damage, steady-state
inactivation left shifts by the same number of millivolts, as depicted in
Figure 3. This gNa-fast(V ) phenomenon we term coupled-left shift (CLS).
Importantly, the “subthreshold persistent current” of pacemaker neurons
(Taddese and Bean, 2002) and of ﬁrst-nodes (Kole, 2011) is a gNa-fast(V ) based
phenomenon, as is CLS. So-called “persistent current inhibitors” (e.g.,
riluzole, ranolazine) principally act by stabilizing non-conducting Relaxed
mode states (large asterisk), but they also cause use-dependent ↓ INa-fast,
perhaps through binding to Active mode channels (Lenkey et al., 2011;
though inhibitor-bound CR states (small asterisk) might contribute to ↓ [CA]
and thence to ↓ [OA]).
By virtue of molecular coupling between the fast-mode acti-
vation and inactivation (availability) processes in a Nav channel
(Banderali et al., 2010), these two processes left shift in synchrony:
if the activation Boltzmann [“m3∞(V )” in Hodgkin–Huxley par-
lance] left shifts by, say, 7 (or 11 or 20. . .)mV, then availability
[“h∞(V )”] left shifts by 7 (or 11 or 20. . .)mV as well. This behav-
ior of fast-mode Nav channels, shown for recombinant Nav1.6
channels in Figures 3A,B we term “coupled-left shift” (CLS).
Crucially, as shown in Figure 3C, Nav-CLS yields a left-shifted
steady-state window conductance [“m3h(V )”]. Here, m3h(V ) is
shown before (black) and after a 20-mV CLS (gray). Note that the
Nav-CLS version of m3h(V ) now peaks at what would normally
be a subthreshold voltage range (i.e., below the normal V rest).
Even if only a fraction (say 10%) of the nodal membrane suffered
damage, that fraction, by virtue of its left-shifted m3h(V ), should
generate a “subthreshold persistent current” that would depolar-
ize the adjacent (intact) Nav-rich membrane, causing the axon to
ﬁre ectopically. Because it facilitates rhythmic ﬁring, a subthresh-
old persistent INa is used by pacemaker neurons (Taddese and
Bean, 2002) and by the ﬁrst node (beyond the axon initial seg-
ment) to elicit rhythmic ﬁring (Kole, 2011), but injury-induced
Nav-CLS based subthreshold persistent INa triggers pathological
ectopic activity. We have modeled the consequences of Nav-CLS
for axonal ion homeostasis and excitability (Boucher et al., 2012).
In a nutshell, Nav-CLS causes [Na+] gradients to run down, it
overtaxes the Na/K-ATPase and, depending on CLS pervasiveness
and severity, produces subthreshold voltage oscillations, bursting,
and diverse other manifestations of hyper -and hypo-excitability.
After ﬁnding that reversible bilayer stretch elicits reversibleNav-
CLS in recombinantNav1.5 (Morris and Juranka,2007),we turned
to recombinant Nav1.6 (Wang et al., 2009). There, irreversible
bilayer damage due to “membrane stretch” (cell-attached patch
clamp, with stretch- and bleb-inducing pipette aspiration) yields
irreversible CLS (Figures 2B,C) whether or not Nav1.6 channels
are co-expressed with β-subunits. Once the irreversible dam-
age has “saturated” (typically producing >20mV of irreversible
CLS), further stretch of the bilayer elicits reversible Nav-CLS
because now, pipette aspiration is indeed causing reversible thin-
ning/disordering (i.e., stretching) of the bilayer. For Nav1.6, as for
Nav1.5 (Morris and Juranka, 2007; Banderali et al., 2010) for com-
fortably non-lytic stretch stimuli, reversible Nav-CLS (Figure 5 in
Wang et al., 2009) is small (typically<5mV).When studied in fast-
mode,Nav1.4 andNav1.2 channels (co-expressedwithβ-subunits)
behave the sameway as fast-modeNav1.6 (CatherineE.Morris and
P. F. Juranka, unpublished observations). It is now known, how-
ever, that expressed in HEK cells Nav1.5 channels exhibit large
substantially irreversible Nav-CLS (Beyder et al., 2010). An inter-
esting possible explanation for the isoform differences in oocytes
is an idea that would be tested by immuno-biochemistry, namely
that in oocytes, Nav1.5 trafﬁcs to bilayer subdomains with a high
degree of disorderliness whereas Nav1.2, Nav1.4, and Nav1.6 traf-
ﬁc to highly ordered cholesterol-rich domains. It would, in fact,
be worth exploiting this stark difference between Nav1.5 and the
other Nav isoforms as a way to correlate channel-lipid interactions
and kinetic behavior.
What appears to be irreversible Nav-CLS arising from meta-
bolic (not mechanical) injury has been reported for the Nav
channels of hippocampal neuronal somata subjected to prolonged
epileptic discharge: the somaticNav channels (presumablyNav1.2)
show a measurably left-shifted Iwindow associated with left-shifted
(fast-mode) activation and availability (Sun et al., 2006). Presum-
ably these overworked neurons are ATP-depleted and their plasma
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FIGURE 2 | (A) From a stretch-traumatized optic nerve, the nodal and
paranodal regions of a node of Ranvier (cartooned by tracing an electron
micrograph, Figure 2A of Maxwell, 1996) showing intact (arrowheads) and
severely blebbed yet unruptured (double-headed arrows) nodal (hence
Nav-rich) axolemma. (B) INa(t ) from recombinant αNav1.6/β1 in a
cell-attached oocyte patch, before (intact) then again after bouts of pipette
aspiration (experimental conditions as in Wang et al., 2009). The changing
INa(t ) (at −50mV) is consistent with increasingly strong coupled-left shift,
the mechanism outlined in Figure 3. (C) In sick excitable cells, Nav
channels that become “leaky,” we assume, experience nano-structural
environmental changes; here we depict a Nav-rich membrane going from
intact (top) to blebbed (bottom). If INa changes such as seen in B are due to
increasing bilayer entropy, then graded structural changes of each channel’s
nano-environments (left) would be expected. If, instead, as suggested by
some (Shcherbatko et al., 1999; but see Morris et al., 2006), pipette
aspiration induced-blebbing alters Nav kinetics by disrupting discrete
channel/cytoskeleton interactions, then each Nav channel will see an
all-or-none structural change, such as depicted at right.
membranes are beset by the usual chemical insults of ischemia.
Skeletal muscles subject to inﬂammatory conditions appear to
have a comparable type of Nav-leak (Haeseler et al., 2008; Nikic
et al., 2011). A recurring theme here is that it will be necessary to
revisit native-Nav channels linked to disease states in Table 1 to
establishwhether CLS correlates broadlywith increasingNav-leak.
FIGURE 3 | Coupled-left shift (Nav-CLS). (A)Traumatic membrane stretch
causes irreversible hyperpolarizing shifts of activation and steady-state fast
inactivation (availability) for recombinant Nav1.6 (aspirated cell-attached
oocyte patches; likewise in B). (B) CLS as seen from INa traces: i, INa(t )
during a step to −15mV before and after stretch-induced membrane
damage – the change is irreversible. ii Nav channels in this patch (same as i)
underwent a membrane-injury-induced CLS found to be of magnitude
20mV, as evidenced by the fact that amplitude-normalized pre/post INa(t )
traces measured at V m steps 20mV apart, as listed, have indistinguishable
time courses (expanded section: pre 5mV, post −15mV traces). CLS like
this is observed whether left shifts are small or large (see Figure 3 of Wang
et al., 2009). This justiﬁes co-left-shifting of HH Boltzmanns, m3∞(V ) and
h∞(V ) (= availability), along the voltage axis (Figure 1 legend) to model
axonal Nav channels in trauma-injured membrane (Boucher et al., 2012). (C)
Activation [m3(V )] and inactivation [h(V )] variables at t =∞ for regular
HH-Nav channels and after each function is left-shifted 20mV (mimicking
intact versus “strongly traumatized”). The product (lower panel) of
overlapping activation and availability Boltzmann’s, m3h(V )= steady-state
open probability or non-dimensional gwindow. Arrows: a 20-mV left-shift
(m3LShLS) increases gwindow near typical V rest while decreasing it nearer 0mV.
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FIGURE 4 | Hyperpolarizing ramps. (A) Recombinant Nav1.6, oocyte patch,
INa elicited by hyperpolarizing ramps from +100 to −100mV, −2mV/ms,
before and after membrane damage. (Bi). Similar data set before stretch then
after increasingly strong ∼20 s bouts of pipette aspiration (conditions as in
(A); further explanation in text). (Bii) Damaged-membrane traces, y -axis
adjusted, as described in text. (C) Simulated INa-ni(V,t ) for “intact” and 20mV
left-shifted non-inactivating HH-type Nav channels (ramps: −2mV/ms). The INa
midpoint shifts ∼−18mV, as expected for the 20-mV shift imposed on m3(V )
[equal-sized INa-ni(V ) and m3 shifts would correspond to inﬁnitely steep
voltage-dependence in mni(V ); see Boucher, 2011]. (D) Simulated
INa(V,t )= (INa-fast + INa-ni) for hyperpolarizing ramps from +150 to −150mV at
−2mV/ms, gni/gNa-fast =0.0075; for control (black) and −20mV shifted (gray).
Total INa(V,t ) (solid lines) mimic experimental traces, given such a gni/gNa-fast
mix; they would be comprised of the two components, as labeled.
BOTH FAST AND SLOW MODE Nav CURRENTS CONTRIBUTE
TO Nav-LEAK
In injured membrane, as will be discussed further in Figure 4 (see
also Figure 2Ciii in Wang et al., 2009), Nav channels gating in
slow mode exhibit left-shifted activation. However, whether slow
inactivation is kinetically coupled to slow activation is unknown
(in parallel to the coupling between fast activation and fast inac-
tivation marked in between OA and IA in Figure 1). Typically,
in a population of Nav channels, ∼1% would be in slow mode.
Though slow mode current (INa-slow) is a kinetically distinct
entity (see Figure 1) from any fast-mode based persistent cur-
rents (the coupled-“m3h” or subthreshold gwindow of Taddese and
Bean, 2002), it too is called persistent current. In computational
models, INa-slow is typically simpliﬁed to a small stand-alone sub-
population of Nav channels with no inactivation process (e.g.,
Coggan et al., 2010). In reality, slow and fast modes interconnect
(Figure 1) and the simplest assumption is that any injured mem-
brane Nav channel (Figure 3) would show CLS when in fast mode
and left-shifted activationwhen in slowmode. Thus,whenwe refer
to “Nav-CLS”-injury, an implicit assumption is that the affected
Nav channels “leak” in both fast and slow modes.
INCREASED ENTROPY AND Nav-CLS
Formally, plasma membrane blebs induced by pipette aspiration
(Sheetz et al., 2006) or other shear forces in the mechanically
traumatized CNS (Maxwell, 1996) are deﬁned as regions of high
ﬂuidity bilayer dissociated from the cortical cytoskeleton. Clearly,
the provenance of such injury-induced blebs differs radically from
that of transient cell-mediated blebs used for ameboid-crawling
(Charras et al., 2009); there, the blebbing-membrane loses its F-
actin (due to precision cortical acto-myosin contractions) while
retaining those elements of the spectrin skeleton needed for re-
adhesion to the cortex. In these motility-blebs, the bilayer, we
expect, would retain much of its healthy, far-from-equilibrium
structure. By contrast, in excitable cell injury (Maxwell, 1996), as
in pipette aspiration induced-blebbing (Morris et al., 2006; Sheetz
et al., 2006), bleb formation, being an externally initiated unregu-
lated process, is governed largely by raw physics. Bilayer structure
in a blebbing-membrane region of a sick excitable cell will, thus,
approach equilibrium, exhibiting increased disorder both verti-
cally (between leaﬂets) and horizontally (within plane). By virtue
of non-speciﬁc electrostatic binding of polar lipid headgroups to
ﬁlamentous cortical proteins (Sheetz et al., 2006) plus the actions
of lipid-ATPases (Shevchenko and Simons, 2010), certain phos-
pholipids like phosphatidylserine are normally disproportionately
high in the inner leaﬂet. As blebs develop, however, this vertical
asymmetry dissipates: artiﬁcial bilayers and dead bilayers are sym-
metrical (Musters et al., 1993; Schlegel and Williamson, 2001; van
Genderen et al., 2008). Simultaneously, lateral phase separation
patterns found among the bilayer lipids will diminish in com-
plexity (Maxwell, 1996; Kaiser et al., 2009; Lingwood and Simons,
2010; Shevchenko and Simons, 2010; Levental et al., 2011): within-
plane organization will become more random, more disordered.
In summary, in the plasmamembrane of sick excitable cells, bilayer
structure will slowly relax toward the minimum energy,maximum
entropy situation of a self-organized bilayer. It is still a bilayer, but
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one with a radically lower information content than the healthy
far-from-equilibrium bilayer that various particular Nav channel
isoforms have come (via evolution) to expect. Additionally, once
it has areas denuded of cortical cytoskeleton, plasma membrane
bilayer should be more prone to inappropriate insertion of intra-
cellular membrane vesicles and to excessive uptake of free fatty
acids (see Figure 1 of Milton and Caldwell, 1990; Morris and
Homann, 2001). The expectation is that damaged Nav-rich bilayer
will be disorderly and that its lipid-species composition too will
render it abnormally ﬂuidized.
Thus, while certain mutant variants of Nav channels are dan-
gerously “leaky” due to structurally defective proteins (Catterall
et al., 2008), Nav-CLS posits that genetically normal Nav channels
in sick excitable cells become dangerously leaky when they ﬁnd
themselves embedded in structurally defective bilayers.
POSITIVE FEEDBACK: FROM SMALL Nav-RICH BLEB TO
LARGE Nav-RICH BLEB
Consider, for a Nav-rich region of an excitable cell membrane
(an axon initial segment, say, or the post-synaptic membrane
of a skeletal muscle end-plate), an initially minor Nav-CLS leak
due to a small bleb. Or, an entire Nav-rich membrane could be
mildly damaged and have a similarly small Nav-CLS leak due,
say, to inﬂammation-induced reactive oxygen species (ROS). A
mild mechanically or chemically induced Nav-CLS leak should
grow via a vicious cycle: the external event (trauma, infection,
ischemia, etc.) degrades plasma membrane structural integrity. As
detailed elsewhere (Morris, 2011a,b,c), abnormally ﬂuidized,more
easily thinnedbilayers, like depolarization, lower the energy barrier
between a voltage sensor’s “down”and“up”conformations, and so
will engender left-shifted Nav gating, i.e., Nav-CLS. The resulting
Na+-leak puts excess demands on Na+/Ca2+ exchangers and on a
cell’s variousATP-drivenpumps.When the demands canno longer
be met an excitotoxic cascade occurs (Wolf et al., 2001; Yuen et al.,
2009). Elevated [Ca2+]intracellular hyperactivates Ca2+-protease-
mediated cleavage of cortical cytoskeleton elements, enlarging the
extent of bleb-like membrane. Via Na-CLS, the initially minor
mechanically induced bleb has subverted cellular processes so
that those processes proceed to damage the Nav-rich membrane’s
bilayer structure. The process is irreversible once Ca2+-protease
dependent spectrin fragments become detectable (McGinn et al.,
2009). In cerebral ischemia (Schafer et al., 2009) and in cardiomy-
ocytes (Weiss et al., 2010) during post-ischemia/reperfusion, the
initial insults that bring on Nav-leak are chemical. Dystrophic
muscle cells are genetically bleb-prone and have left-shifted Nav
availability linked to cell-lethal Nav-leaks (Hirn et al., 2008; Allen
and Whitehead, 2011).
In the hours and days following traumatic or ischemic injury,
mildly damaged excitable cells in “penumbra” zones abutting the
primary insult zones succumb to deepening, self-induced (and,
evidently, tetrodotoxin-sensitive) secondary injury. Thus, for var-
ious model systems there is a tetrodotoxin-sensitive axon loss in
white matter, cell death in gray matter, loss of dystrophic skele-
tal muscle ﬁbers, and, at cardiac infarct border-zones, loss of
cardiomyocytes. Table 1 signiﬁes, we think, that sick excitable
cells that suffer an initially minor Nav-CLS can expect excito-
toxic demise if Nav-CLS based Na+-leak is not stopped either by
membrane remodeling that rids the cells of the damaged Nav-rich
bilayer, or by therapeutic drugs that staunch the leak.
PROTEIN PARTNERS
For Nav1.6 channels expressed in oocytes, injury-induced CLS
phenomena described here occur with or without co-expressed
β subunits (Wang et al., 2009). For that reason, and since virtu-
ally nothing is known about in situ modulatory interactions of
β subunits (or ankyrin-G, or other of Nav channels’ many puta-
tive protein partners, Dib-Hajj and Waxman, 2010), we do not
explicitly deal with them here. On the other hand, our insistence
on how crucial it is to study sick-cell Nav-leak and its attendant
Nav-pharmacology in native and not just recombinant systems,
acknowledges that native lipid structures in conjunction with
diverse protein partners in the immediate vicinity of native-Nav
channels, are likely to determine the speciﬁcs of sick-cell Nav-leak
in different types of excitable cells.
Nav INHIBITORS
Tetrodotoxin, being a pore blocker, inhibits both fast (Active) and
slow (Relaxed) mode Nav channels. Its exclusive selectivity for
Nav channels has made it a powerful tool in cell/tissue models of
disease, as just described. Like many Nav inhibitors, tetrodotoxin
is powerfully protective in cellular models of injury to Nav-rich
excitable membranes (Table 1) but it is a universal Nav-pore
blocker and as such, lethal upon systemic administration. Nav
inhibitors with more appropriate clinical traits include hetero-
cyclic molecules like ranolazine and riluzole (Antzelevitch et al.,
2011; Cadotte and Fehlings, 2011). These lipophilic compounds
preferentially bind and stabilize Nav channels in non-conducting
slow-gating states (Song et al., 1997; Antzelevitch et al., 2011).
Often called“persistent current”blockers, these drugmolecules are
especially effective at stabilizing slowmodeNav innon-conducting
states and at higher concentrations they inhibit fast-mode chan-
nels (Jo and Bean, 2011; Lenkey et al., 2011). Because of severe side
effects (Waxman, 2008), however, none of the available Nav antag-
onists is routinely used to counter thedevastating, slow-developing
consequences of traumatic brain injury described at the neurologi-
cal level as diffuse axonal injury (Wolf et al., 2001; Iwata et al., 2004)
though for spinal injury, riluzole trial are underway (Cadotte and
Fehlings, 2011).
LIPOPHILICITY AND Nav INHIBITOR EFFICACY
Although it is recognized that clinically effective Nav inhibitors
are lipophiles (or strongly lipophilic amphiphiles), what explains
the importance of lipophilicity is unclear (Jo and Bean, 2011;
Lenkey et al., 2011; Nesterenko et al., 2011). We formulate, below,
a two-part hypothesis in which, for sick excitable cells, the known
requirement for lipophilicity in effective Nav antagonists (Lenkey
et al., 2011) correlates with the elevated bilayer-ﬂuidity origin of
Nav-CLS. Before doing so, we direct the reader to Box 1 which
itemizes some physiological, pharmacological, physico-chemical,
and computational ﬁndings that bear on the idea.
To probe riluzole inhibition,Narahashi and colleagues clamped
INa in DRG neurons (Song et al., 1997). Noting the drug’s
enhanced effectiveness in damaged neurons, they invoked
high-afﬁnity binding to the slow-inactivated Nav channels of
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Box 1 A brief history: bilayer partitioning and intra-bilayer orientation of lipophilic/amphiphilic molecules that bind voltage-gated
channels** and other membrane proteins•.
**Herbette et al. (1989) partitioning of dihydropyridines (DHPs) into lipid bilayer could precede binding to voltage-gated Ca2+ channels.
Sarcolemma/buffer partition coefﬁcients: 5,000–150,000 range.
**Mason et al. (1992) voltage-gated Ca2+ channel antagonists and cholesterol. X-ray diffraction and equilibrium binding techniques:
↑membrane cholesterol →marked decrease in DHP partition coefﬁcients (likewise verapamil, diltiazem).
**Mason (1993) Ca2+ channel DHP type antagonists – interactions with bilayers. Lipid composition (e.g., cholesterol content, acyl chain
saturation) effects on membrane partitioning of antagonists should affect bioavailability under normal versus pathological conditions with
altered membrane lipids. Speciﬁcs of bilayer composition may help concentrate and orient drug molecules relative to a hydrophobic binding
site at channel/bilayer interface. For desirable pharmacokinetics, ↑’d efﬁcacy, ↓’d side effects, drug design should anticipate contributions
from membrane lipid compartment.
**Lee and MacKinnon (2004) amphiphilic voltage sensor toxins of arachnid venoms reach their target by partitioning into the lipid bilayer.
Accumulation of toxin where voltage sensors reside and exploiting the free energy of partitioning of appropriately oriented amphiphilic
toxins→high-afﬁnity inhibition.
•Zhang et al. (2007) tetracaine/vesicle interactions: partitioning into solid-gel membrane depends mostly on steric accommodation between
lipids,whereas in liquid-crystallinemembrane (larger inter-lipid distances, lower steric hindrance), hydrophobic and ionic interactions between
tetracaine and lipid molecules predominate. Bilayer partition coefﬁcients ↓’d by cholesterol.
•Baenziger et al. (2008) bilayer lipid composition alters tetracaine action at nicotinic AChRs.
•Eckford and Sharom (2008) cholesterol-modulation of P-glycoprotein-mediated drug transport appears to operate via effects on drug
partitioning into the bilayer and by changes in the protein’s local lipid environment.
•Chisari et al. (2009) GABA-R both speciﬁc (e.g., enantiomer-dependent) and non-speciﬁc (e.g., bilayer partitioning) properties contribute to
potency and longevity of steroid action.
•Lombardi et al. (2009) β2 agonist, indacaterol ﬂuidizes membranes less than salmeterol and yields faster-onset, longer-duration therapeutic
effects, perhaps because of synergy between indacaterol’s better partitioning into raft micro domains and its faster membrane permeation.
**Schmidt and MacKinnon (2008) the mechanical state of bilayer lipids in the plasma membrane is crucial to the efﬁcacy of amphiphilic
peptide toxins that have evolved to bind to and right-shift voltage sensors.
**Milescu et al. (2009) conversion of sphingomyelin to ceramide shows that binding efﬁcacy of an amphiphilic voltage sensor toxin to the
membrane-embedded voltage sensors of Kv channels depends on the bilayer’s lipid composition.
•Ali et al. (2010) loading of drugs (diazepam, ibuprofen, midazolam, propofol) into liposome bilayers is sensitive to cholesterol content: ↑’d
cholesterol=↓’d drug incorporation.
•Tejwani et al. (2011) all-atoms molecular dynamics simulations: a bilayer’s hydrocarbon chain interior is the region most selective to the
chemical structures of drug-type solutes. Multiple discrete polar groups (same solute) contribute additively to bilayer partitioning. Signiﬁcant
orientational preferences for the drugs are evident in speciﬁc bilayer regions.
•Jastrzebska et al. (2011) bilayer composition/organization regulates classic G protein-coupled receptor, rhodopsin.
**Lenkey et al. (2011) lipophilicity is a key factor in Nav antagonist potency, allowing inhibitor molecules to bind at two distinct sites, one most
accessible at hyperpolarized potentials (“resting site”), the other at depolarized potentials (“inactivated site”). In addition, steric/orientation
features involving aromatic rings, hydrogen acceptors, and sheer molecular bulk are important determinants of potency at the inactivated
site.
Relevant to this Box, Muddana et al. (2012) recently showed differential partitioning of non-lipid amphiphiles (vitamin-E, benzyl alcohol,
Triton-X 100) into bilayers depending on mechanical properties of different lipid subdomains.
damage-depolarized cells. In such situations, the Nav channels
of interest are not only in damaged cells, we suggest, but damaged
bilayer. This should affect the working concentration of lipophilic
Nav antagonists (like riluzole) if they partition differently into
damaged versus intact membrane. Further, riluzole efﬁcacy might
be higher in damaged than intact bilayer if its ability to ori-
ent appropriately with respect to intra-bilayer binding sites on
the DRG Nav channels (see Lenkey et al., 2011) is better in less
structured bilayers.
What little we could ﬁnd in the literature relative to these issues
of the partitioning and orientation of lipophilic drugs in different
classes of bilayer structure is summarized in Box 1. Of particu-
lar note, highly ordered, cholesterol-rich membrane subdomains
accumulate lipophilic drugs more poorly than cholesterol-poor
ﬂuidized membranes. Strikingly, the drugs in question are clin-
ically important voltage-gated calcium channel antagonists, the
dihydropyridines. The collection of ﬁndings sketched in Box 1
suggest that at ones peril would one assume bilayer order/disorder
to be irrelevant for the interactions of lipophilic drugs with
dynamic membrane proteins (see also Benabdellah et al., 2009;
Rajendran et al., 2010; Morris, 2011b). To our knowledge, how-
ever, these issues have not been investigated experimentally for
Nav inhibitors.
Lenkey et al. (2011) showed that simple lipophilicity (measured
from oil/water partition coefﬁcients) correlates strongly with Nav
inhibitor efﬁcacy, and, beyond that, that molecular orientation
and steric constraints are particularly important for inhibition of
INa-slow (Lenkey et al., 2011). The possibility that, for sick excitable
cells, clinically useful Nav inhibitors could selectively target the
malfunctioning Nav channels by (1) accumulating preferentially
in disordered bilayers, and (2) exhibiting orientation/steric prop-
erties appropriate for within-bilayer binding to their targets (see
Schmidt and MacKinnon, 2008; Morris, 2011a,b) directly echoes
Mason’s (1993) ideas regarding the dihydropyridines (see Box 1).
It contrasts strikingly, however, with a recent model for the dif-
ferential atrium/ventricle efﬁcacy of ranolazine for (healthy) car-
diac myocyte Nav channels. There, it is explicitly assumed that
drug access to binding sites (Active mode and Relaxed mode
conformations) is via hydrophilic pathways (Nesterenko et al.,
2011).
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HYPOTHESIS: IN SICK EXCITABLE CELLS, BILAYER ENTROPY
ENGENDERS Nav-CLS BUT SIMULTANEOUSLY ENHANCES
THE EFFICACY OF LIPOPHILIC Nav ANTAGONISTS
Against the above background material, we now restate some of
the ideas formally in a two-part hypothesis. The hypothesis is
grounded inourworkon recombinant axon-isoformNav channels
in traumatized membranes (Wang et al., 2009), on Schmidt and
MacKinnon’s (2008) observations on Kv channel activation and
drug interactions in intact versus mechanically disturbed plasma
membranes, and on the Krepkiy et al. (2009) ﬁnding that iso-
lated voltage sensors in “S4-up-states” locally thin/disorder the
bilayer (explained in Morris, 2011a,b,c). In conjunction with the
meta-analysis of Lenkey et al. (2011) for Nav-antagonist physical
chemistry and efﬁcacy, which postulates bilayer-embedded bind-
ing sites for fast and slow mode Nav channel conformations, these
ﬁndings lead us to hypothesize:
H1: Mechanical and/or chemical insult causes the far-from-
equilibrium order of a healthy bilayer to decay toward equilib-
rium, i.e., toward the more disordered dynamically self-organized
arrangement of abiotic bilayers. In injured Nav-rich excitable cells
including neurons, the Nav channels that leak are irreversibly“left-
shifted”due to irreversibly increased bilayer disorder,with the shift
proportionate to the extent of disorder in the Nav-embedding
bilayer;
H2: Because complex lipophilicNav inhibitors in aqueous solu-
tion partition into and may also orient more appropriately in
damaged (disordered) bilayers than in well-packed bilayers of
healthy Nav-rich membranes, lipophilic Nav inhibitors achieve
their best global efﬁcacy precisely at the loci of the leaky Nav
channels.
Our title combines items H1,H2 as a question–hypothesis, and
the question is not rhetorical. The hypothesis moreover, needs to
be tested on native-Nav channels in their native-bilayer settings.
The kinetics of native-Nav channels expressed and maintained at
high-density (Kole et al., 2008) remain poorly understood (Fu
et al., 2011); add trauma (or other sick excitable cell conditions)
and this is even more true. We re-iterate: there is an unmet need
to study the electrophysiological and pharmacological behavior of
native-Nav/bilayer/membrane-skeleton assemblages before, dur-
ing, and after imposing assorted types of membrane damage (see
“A–E” column, Table 1 and Box 1).
Nav-RICH NATIVE MEMBRANES NEED TO BE INVESTIGATED
Myelinated axon INa is carried by Nav1.6 channels (see Chate-
lier et al., 2010). Nodal INa has fast and slow components (Stys
et al., 1993), but the discrete responses of these components to
trauma or ischemia or other bilayer-damaging pathological states
have not, to our knowledge, been studied electrophysiologically.
Assuming fast and slow axonal INa arises from one Nav popula-
tion (Figure 1), damaged axolemma should have co-existing left-
shifted INa-fast (hence left-shifted Iwindow) and left-shifted INa-slow.
Carefully devised (though currently little-used) techniques exist,
fortunately, to study drug actions on INa at voltage clamped nodes
of Ranvier. An understanding of the pharmacological idiosyn-
crasies of nodal Nav1.6 channels in both modes is needed. Voltage
clamp ramps (see Box 2) would be the most feasible way to simul-
taneously monitor fast and slow INa in intact versus damaged
nodal membrane. Based on recombinant Nav1.6 ramp data and
on simulations, the next three sections suggest what to watch for
from nodal Nav1.6 current.
RAMP CLAMP, Nav1.6 CURRENT, AND MEMBRANE DAMAGE
TO DATE
In our recordings of recombinant Nav1.6 current in oocyte
patches, INa-slow was hard to study since usually it was unmea-
surable against background noise (see also Chatelier et al., 2010).
Nevertheless, Figures 4A,B shows ramp-elicited INa traces from
cell-attached oocyte patches. To minimize INa-fast in favor of slow-
gating current,hyperpolarizing rampswere used. TheNav-bearing
membrane patches were injured via pipette aspiration induced-
blebbing. Figure 3A is fromWang et al. (2009) while the Figure 4B
data are from the same group of experiments, included here to
help illustrate Nav1.6 ramp INa(V,t ) during progressively deepen-
ing membrane damage. The ramp-elicited INa(V,t ) progressively
left shifts with stronger damage, its maximal amplitude increases
and, in the gmax region, its slope conductance steepens. Offsets
Box 2 Vaseline-gap voltage clamp of a node of Ranvier.
This technique (Conti et al., 1976; Benoit and Escande, 1991; Schwarz et al., 1995, 2006), though challenging, was the major electrophys-
iological approach used for Nav channel pharmacology several decades ago, before INa-slow was recognized as a pharmacological target.
It would be worth resurrecting the method to study native-Nav1.6 channels in damaged nodes of Ranvier. The speciﬁc aim would be to
perform sawtooth ramp clamp of the nodal axolemma to concurrently detect INa-fast and INa-slow and their responses to membrane damage
and to antagonists. Standard step voltage clamp would be used as well for purposes of technical, biophysical, and pharmacological bench-
marking. In amphibians, nodes yield ∼50nA of INa-fast and 1 nA traces show good signal-to-noise (Conti et al., 1976). Given a gNa-slow/gNa-fast
of ∼1%, peak ramp INa(V) for INa-slow should be ∼0.5 nA. Mechanically traumatizing a node after recording control data is not feasible.
Nodal bilayer damage could, alternatively, be imposed by ATP depletion and/or Ca2+-protease hyperactivation and/or generation of reactive
oxygen species (Dong and Hare, 2005). Cyclodextrin extraction of membrane cholesterol could used to disrupt healthy bilayer structure.
It is possible that accidental stretch, a recognized hazard while mounting axons for vaseline-gap clamp (see Methods section in Schwarz
et al., 1995), could be exploited, or abrupt nerve stretch (Maxwell, 1996) prior to axon dissection. High resolution video-recording at all
stages would allow for blinded post hoc classiﬁcation of trauma (unintentional and intentional) intensity. Whatever the methods used to
damage the nodal bilayer, ancillary imaging, and/or chemical evidence (Rajendran et al., 2010; Shevchenko and Simons, 2010) that initially
intact nodal membranes had incurred structural/compositional damage would needed. Changes to nodal INa-fast and INa-slow would be most
usefully tracked via the hysteresis information from sawtooth clamp.To illustrate, in Figures 4 and 5, we summarize what little information
is available for ramp-elicited total INa(V,t ) from recombinant Nav1.6 channels before and after mechanical membrane damage, then we
simulate some ramp clamp outcomes for a 0.0075 mixture of HH-type Nav channels without and with inactivation.
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FIGURE 5 | Modeling how to dissect fast and slow INa using sawtooth
hysteresis. (A) For gni/gNa-fast =0.0075 (also in B), total INa(V,t ) during
negative (black) and positive-going (gray) voltage ramps of various speeds,
normalized to peak INa for the negative 0.1mV/ms ramp. Positive to
∼−25mV, all plots overlap. Asterisk: speed range of commonly used
depolarizing ramp protocols. (Bi,ii) Current hysteresis (arrows show
direction of ramps) during sawtooth ramp clamp, as labeled, for both INa-fast
and INa-ni [i.e., the total INa(V,t ) hysteresis trace as expected in a control
experiment] and for INa-fast only (expected outcome if a drug inhibited INa-slow
and not INa-fast).
and drift (though largely absent from Figure 4A) are the norm
for INa from ramp clamp, as in Figure 4Bi [in Figure 4Bii, current
offsets in the three post-trauma traces were handled by reposition-
ing traces on the y-axis to a common reversal potential (asterisk,
∼−55mV, ENa), making more evident the post-trauma left shifts
and the steepening slope conductance]. Steeper “gmax” slopes
signify increased numbers of maximally activated Nav channels
and/or greater maximal Popen values. Either way, these INa(V,t )
traces would be consistent with post-trauma “Nav-leak” through
left-shifted Relaxed mode channels. In these experiments, strong
patch-trauma left-shifted fast INa ≥20mV (Wang et al., 2009), but
whether slow and fast INa in a given patch shifted the same amount
was not established.
RUDIMENTARY SIMULATIONS FOR RAMP CLAMP – THE
SIMPLEST MODEL
To concurrently monitor co-existing fast and slow INa in Nav-
rich excitable cells is not straightforward. Simulations can help
with experimental design. For slow INa we simply used gni, a
non-inactivating version of fast gNa [i.e., the usual Hodgkin–
Huxley gNa but with h(V )= 1], with gni/gNa-fast = 0.0075. Even-
tually, more detailed modeling of INa (with slow mode inacti-
vation and mode-switch transitions, Figure 1) will be needed,
but even our rudimentary simulation illustrates some important
points.
In Figure 4C,with fast-mode gNa zeroed, INa-ni(V,t ) is depicted
alone to illustrate the consequence of a left shift. As there is no
inactivation or mode switching, the slope conductance in the gmax
region is ﬁxed.Maximal INa-ni(V,t ) increases because shifted chan-
nels activate where V m − ENa is greater. In Figure 4D the gNa-fast
and gni components are combined (black, control; gray, 20mV
left-shifted). Even though a hyperpolarizing ramp was used and
even though the two-component INa(V,t ) elicited has the look
of “just non-inactivating current,” it is not. Encroaching on the
V m range near typical V rest (arrowhead), the major component
is, in fact, “window current” (Iwindow). Though gni is modeled
as having precisely the same activation characteristics as gNa-fast,
it yields insigniﬁcant Ini in the “subthreshold” V m range where
Iwindow ﬂows, simply because of gNa-fast:gni ratio (>100:1). The
dominance of an Iwindow-based subthreshold Nav-leak could be
consequential, especially if putative therapeutic inhibitors formild
injury were chosen to target gNa-slow.
It is instructive to consider this scenario in light of Nav
inhibitors and trauma. If a mild CLS-type injury depolarized an
axon by a few millivolts, the key Nav-leak for the axon would
be the shifted Iwindow. Accelerated Na/K pumping would be
required to sustain a “resting” V m below the zone ∼10mV more
depolarized (Figure 4D) where Ini-leak starts to take over. The
pharmacological goal, therefore: target the damaged-membrane’s
Nav-CLS channels with lipophilic inhibitors that, at voltages near
V rest, stabilize CR or CA conformations (see Figure 1). Strongly
lipophilic antagonists that readily cross the blood–brain-barrier
(e.g., Weston et al., 2009) would be ideal. While these may be
relatively poorer inhibitors of slow INa (see Lenkey et al., 2011)
staunching the Nav-CLS leak in mildly damaged cells before they
depolarize is the “ﬁrst responder” goal.
With this as the target, it becomes important (in pharmacolog-
ically relevant settings) to better understand what modulates the
ratios of Active to Relaxed channels. This is a question of mode
switching and it is unexplored territory. Inhibiting OA →OR
(Figure 1A) or promoting CR →CA would minimize slow mode
and maximize fast-mode channels. Based on Nav1.4 behavior
in oocyte membranes (Tabarean et al., 1999) we know that in
some cell types, membrane damage can dramatically modulate
Nav channel mode switch transitions: conversion to fast-mode
gating occurs. When examining native-Nav channels’ responses to
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injury, the possibility of mode switch modulation should be borne
in mind.
EXPLOITING THE HYSTERESIS OF SAWTOOTH RAMPS
Figure 5A emphasizes how ramp rate and direction strongly
inﬂuence the “shape”of INa(V,t )= [INa-fast + Ini](V,t ). For either
direction and for all speeds, INa(V,t ) is identical above∼−25mV
since there, only gni is active [in its Popen(V )∼ 1 range]. For
real Nav channels (which undergo slow inactivation), both ramp
speed and direction will affect INa(V,t ) in this range, yielding
information on Relaxed mode (slow) and mode-switch tran-
sitions. Relaxed and Active mode channels are from a single
population dominated by Active mode, and sawtooth protocols
allow for concurrent semi-quantitative monitoring of both. In
membrane-damaged excitable cells, on-going left shift will be
expected, making the system response a “moving target.” More-
over, when following electrophysiologically the consequences of
irreversible membrane damage, damage intensity, and its rate of
change will not be tightly controlled. Within-preparation com-
parisons and time course data are therefore imperative (Tabarean
et al., 1999; Morris et al., 2006; Wang et al., 2009).
With relatively fast ramps, obtaining larger within-preparation
data sets is easier, but as our simulations illustrate, faster ramps
increase the “contamination” of INa(V,t ) by INa-fast (i.e., Iwindow)
even though traces appear to be exclusively “INa-slow” (or, in the
simulated form, Ini). Standard practice in most labs is to use
depolarizing ramps at ∼+0.1–1.0mV/ms, but only at the slow-
est end of this range would Iwindow contamination be minimal.
INa(V,t ) is essentially identical in either direction at +0.1mV/ms,
but fortunately, −2mV/ms is almost as good (Figure 5A). As in
Figure 5Bi, a sawtooth ramp with a fairly speedy depolarizing
limb (i.e., ∼−2mV/ms) can locate the INa-fast(V ) window cur-
rent. The hyperpolarizing counterpart will then reveal the only
slightly “contaminated” slow current. Ramps need not, of course,
be mirror images; the empirical choice is for whatever yields infor-
mative and resolvable hysteresis traces. As membrane damage
deepened, quick sawtooths like this could monitor both compo-
nents’ changes over time. Time course data over minutes could
show whether, at minimal concentrations, lipophilic antagonists
show evidence of accumulating in the bilayer, and if, say, they were
actingmore powerfully on slowor fast components.Depending on
how rapidly injury-related membrane characteristics were chang-
ing, quick sawtooths could make it possible to capture multiple
runs for better signal-to-noise. Intermittently obtained step pro-
tocol I /V data would, of course, be a useful supplement to the
hysteresis data.
In Figure 5Bii, below the two-component hysteresis trace,
is the INa-fast only component. To a ﬁrst approximation, these
hysteresis sets would mimic start and end points of a notional
experiment in which a “persistent current blocker” was added
to the system, fully inhibiting slow mode current while hav-
ing no effect on fast mode current. During Nav-antagonist time
course experiments, changes of this ilk, in combination with
damage-induced left-shifting (Figure 3) would be expected. It
seems unlikely that all this could be captured in a timely fash-
ion via the usual Nav voltage clamp approach of steps-for-INa-fast,
slow-ramps-for-INa-slow.
To re-iterate, continual monitoring of nodal INa(V,t ) hysteresis
via empirically worked-out sawtooth protocols could give a pic-
ture of Active and Relaxed mode Nav protein behavior in injured
axons. For each mode, it could show if/how injury affects suscep-
tibility to Nav antagonists. If Nav agonists showed lower efﬁcacy
in intact versus damaged membrane, this would raise a multi-
tude of ancillary questions regarding the avidity of lipophilic drug
partitioning into intact versus damaged membranes. Compar-
ing inhibitor efﬁcacy time courses in intact (cholesterol-packed)
against cholesterol-extracted membranes (a recognized form of
membrane damage) could, for example, be informative.
OLD IDEA, NEW WRINKLE
Differential partitioning of lipophilic drugs into different mem-
brane subdomains (i.e., intact versus damaged) is a new idea for
Nav channels, but a related concept is now general currency for
G-proteins (Lombardi et al., 2009; Rajendran et al., 2010). Our
proposal for Nav channels has a different twist, since we envis-
age disease states, not normal cell-mediated membrane modeling,
as the factor underlying the therapeutically relevant structural
heterogeneity in excitable Nav-rich membranes. Data have, inter-
estingly, been available onmembrane partitioning of the lipophilic
antagonists of voltage-gatedCa channels for∼20 years.Mason and
colleagues (Box 1, ﬁrst three entries) suggested, moreover, that
these drugs would tend to partition differently into healthy mem-
branes versus ones whose composition was altered due to patho-
logical conditions. At about the same time, however, molecular-
level descriptions of protein structure and of hydrophobic drug
binding sites became increasingly dominant in pharmacology. The
idea that bilayer structure must inﬂuence the activities of mem-
brane proteins (Phillips et al., 2009) was largely put aside (see
discussion in Finol-Urdaneta et al., 2010).
A recent ﬁnding from Andersen’s group (Rusinova et al., 2011),
that initially may seem tangential, is, on closer inspection, entirely
germane to this issue: membrane-ﬂuidizing insulin receptor sen-
sitizers (insulin receptors are G-proteins) at clinically used levels
cause“off-target” left shift of Nav channel gating. In effect,Nav left
shift due to increased bilayer ﬂuidity is such a robust phenomenon
that it can be used as a bioassay for side effects! This, these authors
point out,“underscores the importance of exploring bilayer effects
of candidate drugs early in drug development.” Framed in similar
terms, we stress here the need to establish experimentally whether
bilayer damage in sick excitable cells constitutes a “membrane-
ﬂuidizing Nav-antagonist sensitizer” for Nav channels. If so, it
may be possible to modify antagonists to operate optimally (thus
more selectively) on Nav channels in damaged membranes: this
would be a “silver bullet” scenario – a “bullet” targeting only the
“the bad guys.” MacKinnon and colleagues (Schmidt and MacK-
innon, 2008) among others (Lee and MacKinnon, 2004; Milescu
et al., 2009, see Box 1) reported such an case for an amphiphilic
voltage sensor toxin that targets Kv channels in damaged but not
intact membrane (described in Morris, 2011a,b,c).
If lipophilic Nav antagonists can be ﬁne-tuned for maximal
efﬁcacy in precisely the pathologically ﬂuidized bilayers where
they are most needed, the hoped-for result would be: hyper-
accumulation of a drug that shows ultra-Nav-afﬁnity in“sick”high
entropy bilayers (see Table 1). Given the diversity of Nav channel
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isoforms and the multitude of bilayer-structural features that dif-
ferentiate intact from damaged Nav-rich membranes, silver bullet
antagonists might be possible.
High throughput recombinant channel techniques make
superb preliminary drug screens and could be adapted for ﬁrst
round studies of damaged Nav-bearing membrane. But to design
optimally neuroprotective Nav agents for sick axons, the “retro”
approach of the node of Ranvier vaseline-gap voltage clamp
(Box 2) would be better.
CONCLUDING OVERVIEW
In diverse sick excitable cells, Nav channel leak causes hyperex-
citability and excitotoxicity-induced cell demise (Table 1). Phar-
macological mitigation is poor and side effects too severe (Wax-
man, 2008). There is uncertainty about the nature and subcellular
location of the offending Nav channels and how they are accessed
by clinically promising lipophilic antagonists. We argue that for
pathologies featuring membrane damage, Nav channel operation,
and antagonist binding in damaged versus intact membranes will
be pivotal.
Native-Nav channel kinetics can differ appreciably from kinet-
ics for the same isoform expressed in HEK cells or oocytes
(Tabarean et al., 1999; Fu et al., 2011). The sick-Nav/sick-
bilayer hypothesis presented here will need testing in native set-
tings. The axolemma of a Xenopus sciatic nerve axon would,
for instance, more closely resemble a human myelinated axon
than does the plasma membrane of an undifferentiated human
embryonic kidney cell. Too little is known about how, in cell-
speciﬁc bilayer environments, fast and slow-gating native-Nav
channels (plus whatever protein partners may accompany them)
respond to sick-cell type membrane damage and then to lipophilic
inhibitors. To illustrate how INa-hysteresis data (from sawtooth
ramp clamp of nodes of Ranvier) could facilitate the concurrent
study of fast and slow mode INa during damage and antago-
nist application, we simulated INa for various ramped voltage
stimuli.
Our global hypothesis about sick excitable cells posits that the
primary drug target for lipophilic antagonists is not “axonal Nav
channels” or “cardiac channels” or “skeletal muscle Nav chan-
nels”but sick-bilayer Nav channels. Ignoring the physico-chemical
consequences of bilayer damage could result in sub-optimal pro-
tective antagonists for sick excitable cells. Information on native-
Nav/native-bilayer/Nav-antagonist interactions could underpin
the design of safer neuroprotective drugs, i.e., ones that could be
administered at low enough systemic concentrations to generate
few side effects, while selectively accumulating in the high entropy
bilayer locale of leaky Nav channels.
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